Bioventus to Showcase Full Orthobiologics and Ultrasonic Portfolio at NASS in Chicago
October 12, 2022 08:00 ET
|
Bioventus, Inc.
DURHAM, N.C., Oct. 12, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, will present its spine procedural...
Bioventus to Present at the Morgan Stanley Global Healthcare Conference
August 30, 2022 08:00 ET
|
Bioventus, Inc.
DURHAM, N.C., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, senior vice-president and chief...
Bioventus Reports Second Quarter Results; Updates Full-Year 2022 Financial Guidance
August 11, 2022 07:00 ET
|
Bioventus, Inc.
DURHAM, N.C., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for...
Bioventus Receives FDA 510(k) Clearance for SonaStar Elite
August 03, 2022 07:00 ET
|
Bioventus, Inc.
Innovative New Handpiece Addition to the Nexus Ultrasonic Generator Significantly Expands Company’s Offering in Neurosurgery Ablation Procedures DURHAM, N.C., Aug. 03, 2022 (GLOBE NEWSWIRE) --...
Bioventus to Report Second Quarter of Fiscal Year 2022 Financial Results on August 11, 2022
July 26, 2022 07:00 ET
|
Bioventus, Inc.
DURHAM, N.C., July 26, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report...
Bioventus Completes CartiHeal Acquisition
July 12, 2022 08:30 ET
|
Bioventus, Inc.
DURHAM, N.C., July 12, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that it has completed...
Bioventus Amends CartiHeal Acquisition Structure
June 21, 2022 07:30 ET
|
Bioventus, Inc.
DURHAM, N.C., June 21, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that it has entered...
Bioventus Reports First Quarter Results; Reaffirms Full-Year 2022 Financial Guidance
May 10, 2022 07:00 ET
|
Bioventus, Inc.
DURHAM, N.C., May 10, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for...
Bioventus Cancels Proposed $415 Million Offering of Senior Notes; Reaffirms Full-Year 2022 Financial Guidance
May 03, 2022 17:47 ET
|
Bioventus, Inc.
DURHAM, N.C., May 03, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that its subsidiary,...
Bioventus Agrees to Nationwide Contract with Cigna Commercial Plans for DUROLANE® and GELSYN-3® for Knee Osteoarthritis
May 02, 2022 07:00 ET
|
Bioventus, Inc.
DURHAM, N.C., May 02, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has agreed to a nationwide contract...